The test, developed by Astrin Biosciences, utilizes deep proteomic profiling and a machine learning classifier to identify ...

If you’re working in medical imaging or planning to, you probably know how competitive the field is. But what really sets one ...

THE Ministry of Health recently hosted a comprehensive training closing session to mark the ending of a three-year International Atomic Energy Agency (IAEA) ...

A three-year International Atomic Energy Agency (IAEA) Mammography Project, designed to reduce the burden of breast cancer ...

A Medicare funding freeze and high cost of training new students has left a shortage of workers and blown out wait times of ...

The market is advancing rapidly, powered by AI-driven digital systems that sharpen diagnostic accuracy. A parallel push for health equity is expanding screening access to underserved communities ...

When a radiologist reviewed Deirdre Hall’s mammogram images last summer, everything seemed fine. There were no shadows or lumps or irregular patches that could signal cancer. The doctor gave it a ...

Routine mammograms are the mainstay of breast cancer screening. But, with a new type of analysis powered by artificial intelligence, doctors may be able to also predict whether or not you'll develop ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Women diagnosed with breast cancer at 80 years and older ...

Continued screening mammography after age 80 was associated with a 55% better disease-free survival and 74% reduced risk of death after breast cancer diagnosis. Non-screened women had more advanced, ...

For many older women, the question of whether to continue breast cancer screening has been uncertain. While most guidelines recommend mammograms up to age 74, advice for women 75 and older has been ...

Over the course of several months in 2025, a claim circulated online that Switzerland had become the first nation to ban mammograms – an effective method of screening for breast cancer — citing ...